Literature DB >> 19790113

25-hydroxyvitamin D and cardiovascular risk factors in women with systemic lupus erythematosus.

Peggy W Wu1, Elisa Y Rhew, Alan R Dyer, Dorothy D Dunlop, Craig B Langman, Heather Price, Kim Sutton-Tyrrell, David D McPherson, Daniel Edmundowicz, George T Kondos, Rosalind Ramsey-Goldman.   

Abstract

OBJECTIVE: Low serum levels of 25-hydroxyvitamin D (25[OH]D; vitamin D) are associated with a higher frequency of cardiovascular disease and risk factors in the general population. Vitamin D deficiency has also been noted in systemic lupus erythematosus (SLE). The objective of this study was to evaluate the associations of serum 25(OH)D levels with cardiovascular risk factors in women with SLE.
METHODS: Data collected in 181 women with SLE included demographics, SLE activity and damage assessments, cardiovascular risk factors, medications, and laboratory assessments of inflammatory markers and 25(OH)D levels. Multiple linear and logistic regressions were used to estimate the association of 25(OH)D levels with cardiovascular risk factors.
RESULTS: The mean age and disease duration were 43.2 and 11.9 years, respectively. The mean 25(OH)D level was 27.1 ng/ml and 62.2% had 25(OH)D levels <30 ng/ml. In unadjusted analyses, lower 25(OH)D levels were significantly associated with higher diastolic blood pressure, low-density lipoprotein cholesterol, lipoprotein(a), body mass index (BMI), and fibrinogen levels, as well as self-reported hypertension and diabetes mellitus. Lower 25(OH)D levels were also significantly associated with higher SLE disease activity and damage scores. After adjustment for age, seasonal variation, and race/ethnicity, lower 25(OH)D levels were also significantly related to higher fasting serum glucose. With further adjustment for BMI, associations between 25(OH)D and cardiovascular risk factors were no longer significant.
CONCLUSION: This study demonstrates that vitamin D levels are low in women with SLE and significant associations exist with selected cardiovascular risk factors, although most of these associations can be explained by BMI.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19790113      PMCID: PMC2785856          DOI: 10.1002/art.24785

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  48 in total

1.  Intestinal calcium absorption in exogenous hypercortisonism. Role of 25-hydroxyvitamin D and corticosteroid dose.

Authors:  R G Klein; S B Arnaud; J C Gallagher; H F Deluca; B L Riggs
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

2.  Prevention of immunological disorders in MRL/l mice by a new synthetic analogue of vitamin D3: 22-oxa-1 alpha,25-dihydroxyvitamin D3.

Authors:  J Abe; K Nakamura; Y Takita; T Nakano; H Irie; Y Nishii
Journal:  J Nutr Sci Vitaminol (Tokyo)       Date:  1990-02       Impact factor: 2.000

3.  Effect of glucocorticoids on the arteries in rheumatoid arthritis.

Authors:  Inmaculada del Rincón; Daniel H O'Leary; Roy W Haas; Agustín Escalante
Journal:  Arthritis Rheum       Date:  2004-12

4.  Measurement variability in duplex scan assessment of carotid atherosclerosis.

Authors:  K Sutton-Tyrrell; S K Wolfson; T Thompson; S F Kelsey
Journal:  Stroke       Date:  1992-02       Impact factor: 7.914

5.  1,25-Dihydroxyvitamin D3 attenuates the expression of experimental murine lupus of MRL/l mice.

Authors:  J M Lemire; A Ince; M Takashima
Journal:  Autoimmunity       Date:  1992       Impact factor: 2.815

6.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

7.  Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men.

Authors:  L Lind; A Hänni; H Lithell; A Hvarfner; O H Sörensen; S Ljunghall
Journal:  Am J Hypertens       Date:  1995-09       Impact factor: 2.689

8.  Effects of corticosteroid and 1,24R-dihydroxy-vitamin D3 administration on lymphoproliferation and autoimmune disease in MRL/MP-lpr/lpr mice.

Authors:  T Koizumi; Y Nakao; T Matsui; T Nakagawa; S Matsuda; K Komoriya; Y Kanai; T Fujita
Journal:  Int Arch Allergy Appl Immunol       Date:  1985

9.  Predictive value of noninvasive measures of atherosclerosis for incident myocardial infarction: the Rotterdam Study.

Authors:  Irene M van der Meer; Michiel L Bots; Albert Hofman; Antonio Iglesias del Sol; Deirdre A M van der Kuip; Jacqueline C M Witteman
Journal:  Circulation       Date:  2004-03-01       Impact factor: 29.690

10.  The effects of chloroquine on serum 1,25-dihydroxyvitamin D and calcium metabolism in sarcoidosis.

Authors:  T J O'Leary; G Jones; A Yip; D Lohnes; M Cohanim; E R Yendt
Journal:  N Engl J Med       Date:  1986-09-18       Impact factor: 91.245

View more
  42 in total

1.  Very low levels of vitamin D in systemic sclerosis patients.

Authors:  Paola Caramaschi; Alessandra Dalla Gassa; Orazio Ruzzenente; Alessandro Volpe; Viviana Ravagnani; Ilaria Tinazzi; Giovanni Barausse; Lisa M Bambara; Domenico Biasi
Journal:  Clin Rheumatol       Date:  2010-05-09       Impact factor: 2.980

Review 2.  Does vitamin D affect risk of developing autoimmune disease?: a systematic review.

Authors:  Martin A Kriegel; JoAnn E Manson; Karen H Costenbader
Journal:  Semin Arthritis Rheum       Date:  2010-11-02       Impact factor: 5.532

3.  Depression and Progression of Subclinical Cardiovascular Disease in Systemic Lupus Erythematosus.

Authors:  April Jorge; Apinya Lertratanakul; Jungwha Lee; William Pearce; David McPherson; Trina Thompson; Emma Barinas-Mitchell; Rosalind Ramsey-Goldman
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-11-21       Impact factor: 4.794

4.  Bone geometry profiles in women with and without SLE.

Authors:  Jimmy D Alele; Diane L Kamen; Kelly J Hunt; Rosalind Ramsey-Goldman
Journal:  J Bone Miner Res       Date:  2011-11       Impact factor: 6.741

5.  Calcium and vitamin D supplement intake may increase arterial stiffness in systemic lupus erythematosus patients.

Authors:  Susana Mellor-Pita; Pablo Tutor-Ureta; Silvia Rosado; Khusama Alkadi; Fernando Granado; Carlos Jimenez-Ortiz; Raquel Castejon
Journal:  Clin Rheumatol       Date:  2019-01-09       Impact factor: 2.980

6.  Vitamin D and autoimmune rheumatic diseases.

Authors:  Paola Caramaschi; Alessandra Dalla Gassa; Orazio Ruzzenente; Alessandro Volpe; Viviana Ravagnani; Ilaria Tinazzi; Giovanni Barausse; Lisa M Bambara; Domenico Biasi
Journal:  Clin Rheumatol       Date:  2011-01-18       Impact factor: 2.980

7.  How I treat vitamin d deficiency.

Authors:  Qamar J Khan; Carol J Fabian
Journal:  J Oncol Pract       Date:  2010-03       Impact factor: 3.840

Review 8.  Why are kids with lupus at an increased risk of cardiovascular disease?

Authors:  Catherine Quinlan; Stephen D Marks; Kjell Tullus
Journal:  Pediatr Nephrol       Date:  2015-09-23       Impact factor: 3.714

9.  Disease activity, proteinuria, and vitamin D status in children with systemic lupus erythematosus and juvenile dermatomyositis.

Authors:  Angela Byun Robinson; Myrtle Thierry-Palmer; Keisha L Gibson; Consuelo Egla Rabinovich
Journal:  J Pediatr       Date:  2011-09-15       Impact factor: 4.406

10.  Telomere length in patients with systemic lupus erythematosus and its associations with carotid plaque.

Authors:  Carly Skamra; Juanita Romero-Diaz; Alexander Sandhu; QiQuan Huang; Jungwha Lee; William Pearce; David D McPherson; Kim Sutton-Tyrrell; Richard Pope; Rosalind Ramsey-Goldman
Journal:  Rheumatology (Oxford)       Date:  2013-02-04       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.